Macquarie Group’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Sell |
57,686
-25,741
| -31% | -$710K | ﹤0.01% | 1285 |
|
|
2025
Q1 | $2.37M | Buy |
83,427
+33,865
| +68% | +$960K | ﹤0.01% | 1171 |
|
|
2024
Q4 | $1.52M | Buy |
49,562
+15,884
| +47% | +$486K | ﹤0.01% | 1274 |
|
|
2024
Q3 | $2.25M | Buy |
33,678
+970
| +3% | +$64.8K | ﹤0.01% | 1193 |
|
|
2024
Q2 | $3.88M | Sell |
32,708
-10,027
| -23% | -$1.19M | ﹤0.01% | 1034 |
|
|
2024
Q1 | $4.55M | Buy |
42,735
+4,665
| +12% | +$497K | 0.01% | 987 |
|
|
2023
Q4 | $3.79M | Buy |
38,070
+4,648
| +14% | +$462K | ﹤0.01% | 1032 |
|
|
2023
Q3 | $3.45M | Sell |
33,422
-848
| -2% | -$87.6K | ﹤0.01% | 1016 |
|
|
2023
Q2 | $4.16M | Sell |
34,270
-575
| -2% | -$69.9K | ﹤0.01% | 969 |
|
|
2023
Q1 | $5.35M | Sell |
34,845
-126
| -0.4% | -$19.3K | 0.01% | 924 |
|
|
2022
Q4 | $6.28M | Buy |
34,971
+17,664
| +102% | +$3.17M | 0.01% | 937 |
|
|
2022
Q3 | $2.05M | Sell |
17,307
-141
| -0.8% | -$16.7K | ﹤0.01% | 1221 |
|
|
2022
Q2 | $2.49M | Sell |
17,448
-378,931
| -96% | -$54.1M | ﹤0.01% | 1222 |
|
|
2022
Q1 | $68.3K | Sell |
396,379
-2,161
| -0.5% | -$372 | 0.05% | 417 |
|
|
2021
Q4 | $101M | Sell |
398,540
-413,013
| -51% | -$105M | 0.08% | 303 |
|
|
2021
Q3 | $312M | Sell |
811,553
-702,982
| -46% | -$271M | 0.27% | 77 |
|
|
2021
Q2 | $356M | Buy |
1,514,535
+1,509,612
| +30,664% | +$355M | 0.29% | 75 |
|
|
2021
Q1 | $645K | Buy |
4,923
+810
| +20% | +$106K | ﹤0.01% | 1487 |
|
|
2020
Q4 | $430K | Buy |
4,113
+1,333
| +48% | +$139K | ﹤0.01% | 1477 |
|
|
2020
Q3 | $197K | Buy |
2,780
+116
| +4% | +$8.22K | ﹤0.01% | 1610 |
|
|
2020
Q2 | $171K | Buy |
+2,664
| New | +$171K | ﹤0.01% | 1596 |
|